fluorodeoxyglucose f18 has been researched along with florbetapir f 18 in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 36 (78.26) | 24.3611 |
2020's | 10 (21.74) | 2.80 |
Authors | Studies |
---|---|
Vallabhajosula, S | 1 |
Hsiao, IT; Hsieh, CJ; Hsu, WC; Huang, CC; Kung, MP; Lin, KJ; Wey, SP; Yen, TC | 1 |
Alavi, A; Arnold, SE; Newberg, AB; Rovner, BW; Wintering, N | 1 |
Aisen, PS; Jagust, WJ; Joshi, AD; Koeppe, RA; Landau, SM; Mintun, MA; Petersen, RC; Weiner, MW | 1 |
Kung, HF; Ploessl, K; Zhu, L | 1 |
Bedell, BJ; Carbonell, F; Charil, A; Evans, AC; Zijdenbos, AP | 1 |
Blennow, K; Donohue, M; Insel, PS; Jagust, WJ; Landau, S; Mattsson, N; Shaw, LM; Trojanowski, JQ; Weiner, MW; Zetterberg, H | 1 |
Bailly, M; Camus, V; Gissot, V; Guilloteau, D; Hommet, C; Ribeiro, MJ; Vercouillie, J | 1 |
Adjouadi, M; Barker, W; Cabrerizo, M; Duara, R; Goryawala, M; Loewenstein, D; Zhou, Q | 1 |
Bandy, D; Belden, C; Chen, K; Fleisher, AS; Jacobson, S; Liebsack, C; Liu, X; Luo, J; Malek-Ahmadi, M; Powell, J; Protas, H; Reiman, EM; Rogers, J; Roontiva, A; Sabbagh, MN; Thiyyagura, P | 1 |
Arridge, SR; Atkinson, D; Burgos, N; Cardoso, MJ; Dickson, J; Hutton, BF; Modat, M; Ourselin, S; Schott, JM; Thielemans, K | 1 |
Grothe, MJ; Krause, B; Kurth, J; Teipel, SJ | 1 |
Broski, SM; Dispenzieri, A; Howe, BM; Johnson, GB; Spinner, RJ | 1 |
Fellgiebel, A; Fischer, FU; Scheurich, A; Wolf, D | 1 |
Altmann, A; Greicius, MD; Jagust, WJ; Landau, SM; Ng, B | 1 |
Bottelbergs, A; Kelley, JB; Langlois, X; Schmidt, ME; Staelens, S; Stroobants, S; Waldron, AM; Wintmolders, C | 1 |
Chen, K; Guo, X; Li, R; Long, Z; Wu, X; Xu, L; Yao, L; Zhang, J | 1 |
Bartenstein, P; Brendel, M; Därr, S; Delker, A; Högenauer, M; Rominger, A; Weiss, M | 1 |
Aisen, PS; Donohue, MC; Insel, PS; Jagust, WJ; Mackin, RS; Mattsson, N; Nosheny, RL; Schöll, M; Tosun, D; Weiner, MW | 1 |
For The Alzheimer S Disease Neuroimaging Initiative, EY; Ishii, K; Takahashi, R; Yokoyama, K | 1 |
Chen, K; Guo, X; Hu, B; Wang, P; Wu, X; Yao, L; Ye, Q; Zhang, J | 1 |
Arenaza-Urquijo, EM; Chételat, G; de La Sayette, V; Eustache, F; Fouquet, M; Fradin, S; Gonneaud, J; Perrotin, A | 1 |
Langlois, X; Richardson, JC; Schmidt, M; Staelens, S; Stroobants, S; Verhaeghe, J; Waldron, AM; Wyffels, L | 1 |
Bejanin, A; Horng, A; Jagust, WJ; Landau, SM; Lockhart, SN; Schreiber, F; Schreiber, S | 1 |
Ba, M; Benedet, AL; Chung, CO; Gauthier, S; Kandiah, N; Kang, MS; Li, X; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M | 1 |
Chu, YC; Chuang, WL; Hsiao, IT; Hsieh, CJ; Huang, CC; Huang, CY; Huang, KL; Kung, MP; Kuo, HC; Lin, KJ; Wai, YY; Yen, TC | 1 |
Nation, DA; Yew, B | 1 |
Bartenstein, P; Blautzik, J; Brendel, M; Ishii, K; Kotz, S; Rominger, A; Sauerbeck, J; Vettermann, F; Winter, Y | 1 |
Ben Bouallègue, F; Mariano-Goulart, D; Payoux, P | 1 |
Benedet, AL; Gauthier, S; Kang, MS; Mathotaarachchi, S; Nair, V; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Struyfs, H; Therriault, J; Walpola, IC | 1 |
Choi, H; Jin, KH | 1 |
Asghar, M; Carter, SF; Herholz, K; Hinz, R | 1 |
Aston, JAD; Benedet, AL; Chamoun, M; Cuello, AC; Gauthier, S; Hwang, H; Kang, MS; Mathotaarachchi, S; Misic, B; Mohaddes, S; Parent, MJ; Park, AY; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Therriault, J | 1 |
Bakardjian, H; Corsi, MC; De Vico Fallani, F; Diego Sitt, J; Dubois, B; Epelbaum, S; Gagliardi, G; Gaubert, S; Habert, MO; Hermann, B; Houot, M; Naccache, L; Oudiette, D; Raimondo, F | 1 |
Alavi, A; Khosravi, M; Newberg, AB; Peter, J; Serruya, M; Shamchi, SP; Werner, TJ; Wintering, NA | 1 |
Ceyssens, S; De Roeck, E; Engelborghs, S; Niemantsverdriet, E; Ottoy, J; Staelens, S; Stroobants, S; Van Broeckhoven, C; Verhaeghe, J; Wyffels, L | 1 |
Blazhenets, G; Eidelberg, D; Frings, L; Ma, Y; Meyer, PT; Rücker, G; Schiller, F; Sörensen, A | 1 |
Cai, X; Chen, M; Li, W; Wu, P; Yan, H | 1 |
Adamo, S; Black, SE; Bocti, C; Borrie, M; Chertkow, H; Frayne, R; Gaudet, V; Goubran, M; Hsiung, R; Kuo, PH; Laforce, R; Noseworthy, MD; Prato, FS; Sahlas, DJ; Scott, CJM; Smith, EE; Sossi, V; Soucy, JP; Tardif, JC; Thiel, A; Zukotynski, K | 1 |
Bettendorff, L; Chen, H; Chen, Z; Cirio, R; Flowers, SA; Fonzetti, P; Franchino-Elder, J; Gerber, LM; Gibson, GE; Grandville, T; Habeck, C; Hirsch, JA; Jordan, B; Luchsinger, JA; Schupf, N; Stern, Y; Xu, H | 1 |
Edison, P; Femminella, GD; Harold, D; Scott, J; Williams, J | 1 |
Chen, J; Dong, C; Jing, J; Xie, J; Zhang, F; Zhang, Y; Zhao, L; Zhong, R | 1 |
Bartlett, PF; Jiang, T; Liu, B; Liu, Y; Zhang, Y; Zhou, X; Zhuo, J | 1 |
Ge, Q; Gu, F; Li, P; Li, Y; Lu, J; Ng, YL; Paranjpe, MD; Wang, X; Yan, S; Zhou, Y | 1 |
Bentick, G; Day, J; Fairley, J; Nadesapillai, S; Wicks, I | 1 |
Bao, W; Chen, L; Ding, D; Ge, J; Guan, Y; Ju, Z; Li, M; Liang, X; Lu, J; Ma, X; Wu, J; Wu, P; Xiao, Z; Yen, TC; Zhang, H; Zhao, Q; Zheng, L; Zuo, C | 1 |
2 review(s) available for fluorodeoxyglucose f18 and florbetapir f 18
Article | Year |
---|---|
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzothiazoles; Cerebral Cortex; Dementia; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurofibrillary Tangles; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2011 |
Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Inflammation; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
3 trial(s) available for fluorodeoxyglucose f18 and florbetapir f 18
Article | Year |
---|---|
Relative effect of APOE ε4 on neuroimaging biomarker changes across the lifespan.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Brain; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Heterozygote; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nonlinear Dynamics; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2016 |
Predictive Value of
Topics: Aged; Alzheimer Disease; Aniline Compounds; Cognitive Dysfunction; Diagnosis, Differential; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Predictive Value of Tests | 2020 |
Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glycation End Products, Advanced; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thiamine; Treatment Outcome | 2020 |
41 other study(ies) available for fluorodeoxyglucose f18 and florbetapir f 18
Article | Year |
---|---|
Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cerebrovascular Circulation; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Time Factors | 2012 |
Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index | 2012 |
Amyloid deposition, hypometabolism, and longitudinal cognitive decline.
Topics: Aged; Amyloid; Aniline Compounds; Body Burden; Cognition Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2012 |
Chemistry. Expanding the scope of fluorine tags for PET imaging.
Topics: Alzheimer Disease; Aniline Compounds; Celecoxib; Ethylene Glycols; Fluorescent Dyes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluoxetine; Glucose; Halogenation; Humans; Melanoma; Neoplasms; Patient Selection; Plaque, Amyloid; Positron-Emission Tomography; Pyrazoles; Radiopharmaceuticals; Sulfonamides | 2013 |
β-Amyloid is associated with aberrant metabolic connectivity in subjects with mild cognitive impairment.
Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Genotype; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Cognition Disorders; Cohort Studies; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography | 2015 |
18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Multivariate analysis of structural MRI and PET (FDG and 18F-AV-45) for Alzheimer's disease and its prodromal stages.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Case-Control Studies; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Least-Squares Analysis; Magnetic Resonance Imaging; Male; Multivariate Analysis; Positron-Emission Tomography; Prodromal Symptoms | 2014 |
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
Topics: Adult; Alzheimer Disease; Aniline Compounds; Brain; Down Syndrome; Emergency Services, Psychiatric; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2015 |
Multi-contrast attenuation map synthesis for PET/MR scanners: assessment on FDG and Florbetapir PET tracers.
Topics: Aniline Compounds; Brain; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radioactive Tracers; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis | 2015 |
18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves.
Topics: Amyloid Neuropathies; Amyloidosis; Aniline Compounds; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Altered whole-brain white matter networks in preclinical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Diffusion Tensor Imaging; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Male; Nerve Net; Positron-Emission Tomography; Radiopharmaceuticals; White Matter | 2015 |
Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
Topics: Aged; Aniline Compounds; Atrophy; Brain; Case-Control Studies; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography | 2015 |
In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Brain; Brain Mapping; Carbon Radioisotopes; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Mice, Inbred C57BL; Mice, Transgenic; Phenanthrolines; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2015 |
Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Sensitivity and Specificity | 2016 |
Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Artifacts; Brain; Brain Mapping; Cognitive Dysfunction; Cohort Studies; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2016 |
Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.
Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Atrophy; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis | 2016 |
Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Area Under Curve; Databases, Factual; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2017 |
Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares.
Topics: Aged; Aniline Compounds; Brain; Cognitive Dysfunction; Dermatitis, Allergic Contact; Discriminant Analysis; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Least-Squares Analysis; Linear Models; Magnetic Resonance Imaging; Male; Methacrylates; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Support Vector Machine | 2016 |
Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Brain; Disease Models, Animal; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Positron-Emission Tomography; Presenilin-1; Time Factors | 2017 |
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe | 2017 |
Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Biomarkers; Brain; Brain Mapping; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Irritable Mood; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Prodromal Symptoms; Prognosis; Radiopharmaceuticals; Sleep; tau Proteins | 2017 |
Dual-phase
Topics: Aged; Alzheimer Disease; Aniline Compounds; Aphasia, Primary Progressive; Brain; Case-Control Studies; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Taiwan | 2017 |
Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Atrophy; Blood Pressure; Brain; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Spin Labels; Vascular Resistance; White Matter | 2017 |
Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
Topics: Adaptor Proteins, Signal Transducing; Aged; Amyloid; Aniline Compounds; Apolipoprotein E4; Body Mass Index; Brain; Cognition; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Heterozygote; Humans; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Repressor Proteins; Weight Loss; Zebrafish Proteins | 2018 |
Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Brain Mapping; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.
Topics: Aged; Agnosia; Amyloid; Aniline Compounds; Apolipoprotein E4; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Prognosis; Radiopharmaceuticals | 2018 |
Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine | 2018 |
Dual-phase [18F]florbetapir in frontotemporal dementia.
Topics: Aniline Compounds; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography | 2019 |
Aβ-induced vulnerability propagates via the brain's default mode network.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Animals, Genetically Modified; Brain; Cognitive Dysfunction; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neural Pathways; Neurofibrillary Tangles; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2019 |
EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain Waves; Case-Control Studies; Disease Progression; Electroencephalography; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nerve Degeneration; Positron-Emission Tomography; Prodromal Symptoms | 2019 |
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Cerebrovascular Circulation; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Severity of Illness Index | 2019 |
Associations of cigarette smoking with memory decline and neurodegeneration among cognitively normal older individuals.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Brain; Case-Control Studies; Cigarette Smoking; Cognition; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Healthy Volunteers; Hippocampus; Humans; Male; Memory; Organ Size; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2020 |
The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score.
Topics: Aged; Amyloid; Aniline Compounds; Brain; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Machine Learning; Male; Middle Aged; Positron-Emission Tomography | 2020 |
The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Endocytosis; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Immunity; Linear Models; Lipid Metabolism; Male; Multifactorial Inheritance; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Cognition; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Male; Mental Status and Dementia Tests; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography; Severity of Illness Index | 2021 |
New Trajectory of Clinical and Biomarker Changes in Sporadic Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Tracer-specific reference tissues selection improves detection of
Topics: Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Carbolines; Cognitive Dysfunction; Cross-Sectional Studies; Ethylene Glycols; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2022 |
Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.
Topics: Alzheimer Disease; Cognition; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; tau Proteins | 2023 |